Inactive Instrument

Presbia PLC

Equities

LENSF

IE00BJ0X7W22

Advanced Medical Equipment & Technology

Presbia PLC Auditor Raises 'Going Concern' Doubt

January 25, 2014 at 03:08 am IST

Presbia PLC filed its DRS/A on Jan 24, 2014 for the period ending Dec 31, 2012. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Latest news about Presbia PLC

Presbia PLC(OTCPK:LENS.F) dropped from S&P TMI Index	29/19/29	CI
Presbia PLC Announces Management Changes	27/19/27	CI
Presbia PLC(OTCPK:LENS.F) dropped from NASDAQ Composite Index	24/19/24	CI
Presbia PLC Announces Executive Changes	23/19/23	CI
Presbia plc Reports Earnings Results for the Full Year Ended December 31, 2018	13/19/13	CI
Presbia PLC Auditor Raises 'Going Concern' Doubt	12/19/12	CI
Presbia PLC Announces Management Changes	02/19/02	CI
Presbia PLC announced that it has received $0.1 million in funding	10/18/10	CI
Presbia PLC announced that it has received $0.1 million in funding	12/18/12	CI
Presbia PLC Auditor Raises 'Going Concern' Doubt	30/18/30	CI
Presbia plc Announces the Resignation of Magda Michna as Chief Clinical Officer, Effective March 30, 2018	22/18/22	CI
Presbia PLC Announces Resignation of Vladimir Feingold from the Board of Directors	22/18/22	CI
Presbia PLC Announces New Management Appointments	14/18/14	CI
Presbia PLC Announces Management Changes	10/18/10	CI
Presbia PLC Announces Management Changes	15/17/15	CI
Presbia PLC Announces Management Changes	19/17/19	CI
Presbia PLC Provides Update on U.S. Staged Pivotal Clinical Trial	23/16/23	CI
Presbia Seeks Acqusitions	05/16/05	CI
Presbia PLC Appoints Jarett Fenton as Chief Financial Officer	16/16/16	CI
Presbia PLC Completes 6-Month Post-Operative Visits	31/16/31	CI
Presbia PLC Seeks Acquisition	15/16/15	CI
Presbia Announces First Patients in Presbia Microlens Fda Study Complete 12-Month Postoperative Visits	01/16/01	CI
Presbia PLC announces the Resignation of Richard Fogarty as Chief Accounting Officer, Vice President, Finance and Secretary, Effective March 31, 2016	12/16/12	CI
Presbia PLC Appoints Gerald Farrell, Ph.D. to Serve on the Board of Directors and as A Member of Audit Committee	21/16/21	CI
Presbia Introduces Time-Saving Disposable Microlens Inserter	05/15/05	CI

Chart Presbia PLC

Duration

Period

More charts

Company Profile

Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. It operates through the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company's lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient's eye to improve that patient's ability to see objects at close distances. Its microlens is a disc-shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia. The Company's solution is intended primarily for emmetropic-presbyopes, or those individuals who suffer from presbyopia but do not have any other visual disorder. The Company has its manufacturing capacity in Irvine, California.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+4.85%	212B
DANAHER CORPORATION	+9.86%	188B
INTUITIVE SURGICAL, INC.	+31.11%	157B
BOSTON SCIENTIFIC CORPORATION	+34.08%	114B
SIEMENS HEALTHINEERS AG	+2.89%	64.01B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+1.63%	48.83B
AGILENT TECHNOLOGIES, INC.	-3.12%	39.3B
GE HEALTHCARE TECHNOLOGIES INC.	+1.93%	35.97B
RESMED, INC.	+6.87%	27B

Other Advanced Medical Equipment & Technology